Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
71 CHF | 0.00% | +1.72% | +39.49% |
18/06 | Switzerland's Cosmo Pharmaceuticals Receives Drug Registration Certificate for Lumeblue in China | MT |
03/06 | Cosmo Pharmaceuticals Swings to Loss in FY23; Revenue Down | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+39.49% | 126.1Cr | |
+54.07% | 82TCr | |
+38.59% | 63TCr | |
-7.05% | 35TCr | |
+15.44% | 32TCr | |
+5.72% | 29TCr | |
+13.40% | 24TCr | |
+0.61% | 22TCr | |
+13.24% | 22TCr | |
+7.42% | 17TCr |
- Stock Market
- Equities
- COPN Stock
- News Cosmo Pharmaceuticals N.V.
- Cosmo Pharmaceuticals Secures Over 93% Stake in Cassiopea at Tender Closing